| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 11/24/2005 | WO2005111612A1 Diagnosing and monitoring inflammatory diseases by measuring complement components on white blood cells |
| 11/24/2005 | WO2005111611A2 Methods and apparatus for facilitating analysis of large data sets |
| 11/24/2005 | WO2005111610A2 Method of assessing the risk of atherosclerosis |
| 11/24/2005 | WO2005111609A2 Methods for rapid screening of mad cow disease and other transmissible spongiform encephalopathies |
| 11/24/2005 | WO2005111608A2 Transmissible spongiform encephalopathy test reagents and methods using them |
| 11/24/2005 | WO2005111607A2 Method for increasing the dynamic measuring range of test elements, especially immunological test elements, that are based on specific bonding reactions |
| 11/24/2005 | WO2005111606A2 Use of a film having a hydrophilic surface in medical diagnostic strips |
| 11/24/2005 | WO2005111605A2 Biomarkers for the prediction and treatment of drug-induced diarrhoea |
| 11/24/2005 | WO2005111604A1 Method for on-line monitoring of condition of non-aqueous fluids |
| 11/24/2005 | WO2005111603A1 Method and device for determining oil characteristics of geological sediments |
| 11/24/2005 | WO2005111602A2 Multi-sensor system for fluid monitoring with selective exposure of sensors |
| 11/24/2005 | WO2005111601A2 Fluid treatment apparatus with input and output fluid sensing |
| 11/24/2005 | WO2005111596A1 Magnetic rotation to improve signal-over-background in biosensing |
| 11/24/2005 | WO2005111594A1 Method and apparatus for analysis through selective cleavage of noncovalent bond, etc. of biopolymer |
| 11/24/2005 | WO2005111588A1 Colorimetric sensor |
| 11/24/2005 | WO2005111583A1 Method for nondestructively examining component of vegetable or the like by near-infrared spectroscopy and its device |
| 11/24/2005 | WO2005111579A1 Transmission-based luminescent detection systems |
| 11/24/2005 | WO2005111578A1 Techniques for controlling the optical properties of assay devices |
| 11/24/2005 | WO2005111577A1 Electroluminescent illumination source for optical detection systems |
| 11/24/2005 | WO2005111575A1 Measuring device, equipment and method for monitoring the onset of corrosion affecting steel reinforcements embedded in reinforced concrete |
| 11/24/2005 | WO2005111553A2 Method for compensation of near-neighbor sample effects in a nmr check weighing system |
| 11/24/2005 | WO2005111513A1 Demand controlled ventilation system with central air quality measurement and method herefor |
| 11/24/2005 | WO2005111243A2 Multiplexed detection of biological agents |
| 11/24/2005 | WO2005111234A2 Methods of using zc1 and zc3 kinase substrate phosphorylation as biomarkers |
| 11/24/2005 | WO2005111233A2 Methods and kits to detect hereditary angioedema type iii |
| 11/24/2005 | WO2005111231A2 Compositions, kit and one-step method for monitoring compounds having anti-factor xa and/or anti factor iia activities |
| 11/24/2005 | WO2005111228A1 Method of assaying substance capable of changing mitochondrial membrane potential |
| 11/24/2005 | WO2005111221A1 Recombinant lentiviral vector for expression of a flaviviridae protein and applications thereof as a vaccine |
| 11/24/2005 | WO2005111213A1 Target gene mimitin of myc |
| 11/24/2005 | WO2005111198A1 Cancerous disease modifying antibodies |
| 11/24/2005 | WO2005111196A1 Conserved inner core lipopolysaccharide epitopes as multi-species vaccine candidates |
| 11/24/2005 | WO2005111174A1 Polymeric matrices for the encapsulation of phosphorescent molecules for analytical applications |
| 11/24/2005 | WO2005111076A1 Nectin 4 (n4) as a marker for cancer prognosis |
| 11/24/2005 | WO2005111071A1 Complex containing protein with ligand binding capacity, and method of screening substance capable of binding to protein with ligand binding capacity |
| 11/24/2005 | WO2005110955A1 Substituted acetophenome as ms reagents |
| 11/24/2005 | WO2005110490A1 Phospholipase c gamma modulation and uses thereof for management of pain and nociception |
| 11/24/2005 | WO2005110479A2 Treatments for pancreatic cancer |
| 11/24/2005 | WO2005110476A1 Method of inhibiting telomerase activity and inhibitor |
| 11/24/2005 | WO2005110461A2 Leptin peptide antagonists |
| 11/24/2005 | WO2005110460A2 Diagnosis and treatment methods related to aging, especially in muscle (14.1) |
| 11/24/2005 | WO2005110459A2 Method of inducing immunity against stratum corneum chymotrytic enzyme |
| 11/24/2005 | WO2005110433A1 Nonhuman animal having expression of bach2 artificially inhibited, and use thereof |
| 11/24/2005 | WO2005110207A1 Optical sensor for in vivo detection of analyte |
| 11/24/2005 | WO2005110109A2 Colorimetric and fluorometric determination of homocysteine and cysteine |
| 11/24/2005 | WO2005110079A2 Scent identification apparatus and method |
| 11/24/2005 | WO2005110035A2 Monitoring systems and methods for fluid testing |
| 11/24/2005 | WO2005095646A3 Episomal expression system |
| 11/24/2005 | WO2005091199A3 A method for identifying unknown proteins by a two-dimensional step and the use of markers |
| 11/24/2005 | WO2005088310A3 High throughput glycan microarrays |
| 11/24/2005 | WO2005086594A3 Measurement value lowering inhibitor for immunoassay method and immunoassay method using the same |
| 11/24/2005 | WO2005085469A3 Diagnostics and therapeutics for diseases associated with rho-associated protein kinase 1 (rock1) |
| 11/24/2005 | WO2005083445A3 Methods for determining the effects of products on epithelial tissue |
| 11/24/2005 | WO2005080593A3 P53 wild-type as biomarker for the treatment with mtor inhibitors in combination with a cytotoxic agent |
| 11/24/2005 | WO2005078453A3 Proteome epitope tags and methods of use thereof in protein modification analysis |
| 11/24/2005 | WO2005076003A3 Diagnostics and therapeutics for diseases associated with plasma glutamate carboxypeptidase (pgcp) |
| 11/24/2005 | WO2005076001A3 A polypeptide derived from gp41, a vaccine composition comprising said polypeptide, and uses for treating an infection by an hiv virus in an individual |
| 11/24/2005 | WO2005074681A3 Apparatus and method for determining effects of a substance on an organ |
| 11/24/2005 | WO2005071400A3 Screening model |
| 11/24/2005 | WO2005065354A3 Defined media for pluripotent stem cell culture |
| 11/24/2005 | WO2005064340A3 Method for serological diagnosis and determination of immunisation status, comprising various controls |
| 11/24/2005 | WO2005062849A3 Lifespan management |
| 11/24/2005 | WO2005060951A3 Anti-neoplastic agents, combination therapies and related methods |
| 11/24/2005 | WO2005059508A3 Cellular probes |
| 11/24/2005 | WO2005057160A3 Paper producing device |
| 11/24/2005 | WO2005041893A3 Detection of acute myocardial infarction biomarkers |
| 11/24/2005 | WO2005039389A3 Sequence-based karyotyping |
| 11/24/2005 | WO2005037083A3 Mn/ca ix and cancer prognosis |
| 11/24/2005 | WO2005033132A3 Igf binding proteins |
| 11/24/2005 | WO2005026178A3 Electrochemical affinity biosensor system and methods |
| 11/24/2005 | WO2004104217A3 Protein kinase c zeta as a drug target for arthritis and other inflammatory diseases |
| 11/24/2005 | WO2004104177A3 Methods for localizing target molecules in a flowing fluid sample |
| 11/24/2005 | WO2004102181A3 Determination of aromatic hydrocarbons in edible oil products |
| 11/24/2005 | WO2004045512A3 Human monoclonal antibodies against cd25 |
| 11/24/2005 | WO2004042346A3 Methods and compositions for diagnosing and monitoring transplant rejection |
| 11/24/2005 | WO2003087768A3 Targets for therapeutic intervention identified in the mitochondrial proteome |
| 11/24/2005 | WO2003052121A3 Method of reducing angiogenesis |
| 11/24/2005 | US20050262194 User interface service for a services oriented architecture in a data integration platform |
| 11/24/2005 | US20050262193 Logging service for a services oriented architecture in a data integration platform |
| 11/24/2005 | US20050262192 Service oriented architecture for a transformation function in a data integration platform |
| 11/24/2005 | US20050262191 Service oriented architecture for a loading function in a data integration platform |
| 11/24/2005 | US20050262190 Client side interface for real time data integration jobs |
| 11/24/2005 | US20050262189 Server-side application programming interface for a real time data integration service |
| 11/24/2005 | US20050262188 Multiple service bindings for a real time data integration service |
| 11/24/2005 | US20050262108 Methods and apparatus for facilitating analysis of large data sets |
| 11/24/2005 | US20050261837 Kernel-based system and method for estimation-based equipment condition monitoring |
| 11/24/2005 | US20050261836 Crystal structure of mitogen-activated protein kinase-activated protein kinase 2 and binding pockets thereof |
| 11/24/2005 | US20050261606 Percutaneous biological fluid constituent sampling and measurement devices and methods |
| 11/24/2005 | US20050261605 System for monitoring the health of an individual and method for use thereof |
| 11/24/2005 | US20050261508 Aminosterol compounds useful as inhibitors of the sodium/proton exchanger (NHE), pharmaceutical methods and compositions employing such inhibitors, and processes for evaluating the NHE-inhibitory efficacy of compounds |
| 11/24/2005 | US20050261486 Compositions and methods for binding agglomeration proteins |
| 11/24/2005 | US20050261485 Method of producing antisense oligonucleotide |
| 11/24/2005 | US20050261482 Regulation of human serine-threonine protein kinase |
| 11/24/2005 | US20050261480 Super humanized antibodies |
| 11/24/2005 | US20050261472 Binding moieties for fibrin |
| 11/24/2005 | US20050261367 Methods for treating dermatological and other health-related conditions in a patient |
| 11/24/2005 | US20050261338 Beta2-adrenergic receptor agonists |
| 11/24/2005 | US20050261270 Modified beta-lactamases and uses thereof |
| 11/24/2005 | US20050261265 modulating cellular senescence in vitro by introducing a polynucleotide (gDNA or cDNA) encoding an amphiphysin-1 protein; genetic engineering; genetic disorders, premature aging |
| 11/24/2005 | US20050261229 Fc fusion proteins for enhancing the immunogenicity of protein and peptide antigens |
| 11/24/2005 | US20050261224 Methods of modulating immune responses by modulating tim-1, tim-2 and tim-4 function |